Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Subcommittee delays Sickles bill on formularies after debate over rebates and patient access to generics
Summary
Delegate Jeff Sickles presented House Bill 2329, a measure intended to speed patient access to new generics and biosimilars and to make health plan formularies more transparent.
Delegate Jeff Sickles presented House Bill 2329, a bill aimed at speeding coverage of newly approved generic drugs and biosimilars and requiring clearer public disclosure of plan formularies and restrictions.
The bill would require plans to publish an "up‑to‑date, accurate and complete list" of covered drugs, including tiering and restrictions, in a clearly identifiable way on public websites and to ensure that new lower‑cost generics and biosimilars achieve rapid formulary placement when their net price to the plan is lower. "Policymakers should ensure rapid formulary coverage of new generics and biosimilars and provide that patients receive the full value of lower cost medicines," Sickles…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
